Business · 09/10/2026Updated: 10/15/2026 · 1 min read
Determination of Regulatory Review Period for Purposes of Patent Extension; MONOFERRIC
Summary
The Food and Drug Administration (FDA) has determined the regulatory review period for MONOFERRIC and published a notice of that determination as required by law.
Original source language: Federal Register — Health and Human ServicesOpen original release →